These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34060176)

  • 1. Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathy.
    Subréville M; Bonello-Palot N; Yahiaoui D; Beloribi-Djefaflia S; Fernandes S; Stojkovic T; Cassereau J; Péréon Y; Echaniz-Laguna A; Violleau MH; Soulages A; Louis SL; Masingue M; Magot A; Delmont E; Sacconi S; Adams D; Labeyrie C; Genestet S; Noury JB; Chanson JB; Lévy N; Juntas-Morales R; Tard C; Sole G; Attarian S
    Eur J Neurol; 2021 Sep; 28(9):2913-2921. PubMed ID: 34060176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
    Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME;
    Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical spectrums in Korean Charcot-Marie-Tooth disease patients with myelin protein zero mutations.
    Kim HJ; Nam SH; Kwon HM; Lim SO; Park JH; Kim HS; Kim SB; Lee KS; Lee JE; Choi BO; Chung KW
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1678. PubMed ID: 33825325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype characteristics and baseline natural history of Chinese myelin protein zero gene related neuropathy patients.
    Lei L; Xiaobo L; Zhiqiang L; Yongzhi X; Shunxiang H; Huadong Z; Beisha T; Ruxu Z
    Eur J Neurol; 2023 Apr; 30(4):1069-1079. PubMed ID: 36692866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
    Speevak MD; Farrell SA
    Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study.
    Fridman V; Sillau S; Bockhorst J; Smith K; Moroni I; Pagliano E; Pisciotta C; Piscosquito G; Laurá M; Muntoni F; Bacon C; Feely S; Grider T; Gutmann L; Shy R; Wilcox J; Herrmann DN; Li J; Ramchandren S; Sumner CJ; Lloyd TE; Day J; Siskind CE; Yum SW; Sadjadi R; Finkel RS; Scherer SS; Pareyson D; Reilly MM; Shy ME;
    Ann Neurol; 2023 Mar; 93(3):563-576. PubMed ID: 36203352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
    Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
    Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
    Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
    Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
    Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype.
    Callegari I; Gemelli C; Geroldi A; Veneri F; Mandich P; D'Antonio M; Pareyson D; Shy ME; Schenone A; Prada V; Grandis M
    J Neurol; 2019 Nov; 266(11):2629-2645. PubMed ID: 31278453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysmyelinating and demyelinating Charcot-Marie-Tooth disease associated with two myelin protein zero gene mutations.
    Drac H; Kabzińska D; Moszyńska I; Strugalska-Cynowska H; Hausmanowa-Petrusewicz I; Kochański A
    J Appl Genet; 2011 May; 52(2):177-83. PubMed ID: 21107784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin protein zero mutation-related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort.
    Bremer J; Meinhardt A; Katona I; Senderek J; Kämmerer-Gassler EK; Roos A; Ferbert A; Schröder JM; Nikolin S; Nolte K; Sellhaus B; Popzhelyazkova K; Tacke F; Schara-Schmidt U; Neuen-Jacob E; de Groote CC; de Jonghe P; Timmerman V; Baets J; Weis J
    Brain Pathol; 2024 Jan; 34(1):e13200. PubMed ID: 37581289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot-Marie-Tooth Disease with Myelin Protein Zero Mutation Presenting as Painful, Predominant Small-Fiber Neuropathy.
    Gemignani F; Percesepe A; Gualandi F; Allegri I; Bellanova MF; Nuredini A; Saccani E; Ambrosini E; Barili V; Uliana V
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene.
    Auer-Grumbach M; Strasser-Fuchs S; Robl T; Windpassinger C; Wagner K
    Neurology; 2003 Nov; 61(10):1435-7. PubMed ID: 14638973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
    Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
    Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
    Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
    J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.